Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display

News
Jun.26
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.

Key Points

  •  The bill has passed Ireland’s Dáil.
  • Vape flavours would be limited to tobacco or unflavoured.
  • Retail advertising and mixed-store displays would be restricted.
  •  Nicotine pouch sales to minors would be banned.

2Firsts

June 26, 2026

According to Irish Examiner, Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will be sent to the Seanad. The bill would further restrict vape flavours, packaging, retail advertising and in-store displays, while creating clearer baseline regulation for “nicotine consumption products” such as nicotine pouches.

Flavour and Packaging Rules Tighten

Under the bill, Ireland would limit flavours in nicotine inhaling products to tobacco or unflavoured. That means fruit, dessert, beverage, ice and other flavoured vapes would face sales restrictions. The bill would also ban flavour descriptors and marketing language beyond basic flavour names, reducing the appeal of such products to younger consumers.

The bill would also restrict colours and imagery on nicotine inhaling product devices and packaging. Irish Examiner reported that the proposed measures include curbs on bright colours, imagery and device or packaging designs that may appeal to minors.

From an industry perspective, flavour and packaging restrictions will directly affect vape brands’ product portfolios, SKU planning and visual identity. If enacted in its current direction, the Irish vape market would move away from flavour-led differentiation toward a more standardized and lower-visibility compliance model.

The bill still needs to be debated in the Seanad. The Irish Government is also expected to receive EU notification in the coming weeks on whether the bill can be enacted before the summer recess. That process will be important for the implementation timetable.

Retail Advertising and Display Restricted

The bill would prohibit advertising of nicotine inhaling products and nicotine consumption products in all retail outlets and ban point-of-sale display in mixed retail outlets. Mixed retailers typically include convenience stores and community retailers that sell food, daily goods, tobacco or other products alongside vapes or nicotine products.

This would move vapes and nicotine products closer to traditional tobacco-style retail controls. For convenience stores and mixed retailers, product display, shelf position, in-store promotional materials and counter visibility could all be affected.

Retail changes could reshape brand exposure. In many European markets, vapes have relied on packaging colour, flavour naming and point-of-sale display for consumer recognition. If advertising and display are restricted, brands may need to rely more heavily on compliant channels, adult-consumer education and pricing.

The bill would also introduce further enforcement measures and related offences. For retailers, compliance costs may come from staff training, covering or removing displays, clearing advertising materials, age verification and differentiating between product categories at the point of sale.

Nicotine Pouches Enter Baseline Regulation

Beyond vapes, the bill covers “nicotine consumption products” such as nicotine pouches. According to Irish Examiner, it would ban the sale of nicotine consumption products, including pouches, to under-18s and place restrictions on retail advertising and sales practices.

During the Dáil debate, Social Democrats TD Pádraig Rice pushed to include nicotine pouches in packaging restrictions. He said pouches are currently displayed in shops in bright, colourful packaging and are becoming increasingly popular among teenagers.

Minister of State for Public Health Jennifer Murnane O’Connor said the bill already contains restrictions on pouches. She said accepting the packaging amendment would require a new notification to the EU and could delay full operation of the bill by up to a year.

Ireland’s Department of Health previously said the inclusion of novel nicotine products is intended to be “future-proofed,” applying not only to products currently on the market but also to any new nicotine products that emerge.

Murnane O’Connor said she regularly hears concerns from parents and teachers about children’s use of nicotine products. She said nicotine is highly addictive and that evidence shows young people who vape are more likely to take up smoking. She also acknowledged that the measures will affect some businesses, but said government decisions are health-led.

For the industry, Ireland’s bill signals that regulation is moving from e-cigarettes to the broader market for non-medicinal recreational nicotine products. Vape brands, nicotine pouch brands, convenience stores and specialist retailers will need to assess the commercial impact of flavour, packaging, display, advertising and age-limit rules.

Key issues to watch next include the Seanad debate, the EU notification process, the implementation timetable and whether nicotine pouches will later face additional packaging and colour restrictions.

Follow 2Firsts for the latest updates on global tobacco harm reduction, nicotine products and regulatory developments.

 

Cover image:generated by AI

 

Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
Japan Tobacco International is stepping up its heated tobacco push in South Korea with Ploom AURA. Since its official launch in April 2026, the device's limited First Edition and Glacier White version have sold out, while distribution has expanded across Seoul, Incheon, Gyeonggi Province and airport duty-free channels. The rollout marks JTI's third major attempt to build a stronger heated tobacco position in South Korea, following Ploom TECH in 2019 and Ploom X Advanced in 2024. At the group level, JT plans to invest about ¥800 billion, approximately $5 billion, in reduced-risk products from 2026 through 2028, with heated products and Ploom identified as its primary investment priority.
Aug.14
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07